214390.KO Kyongbo Pharmaceutical Co Ltd

Healthcare Pharmaceuticals Korea Stock Exchange
5,110 KRW
Close of Nov 4, 2026
4,700 9,300
Market cap
KRW 122B
P/E
24.3x
P/B
0.82x
ROE
3.3%
Dividend yield
0.98%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 214390.KO undervalued?

Graham number
Price5,110
Graham value5,414
Discount5.6%

214390.KO trades 5.6% below its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Kyongbo Pharmaceutical Co Ltd fundamental analysis

No fundamental analysis for Kyongbo Pharmaceutical Co Ltd yet.

Kyongbo Pharmaceutical Co Ltd stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Kyongbo Pharmaceutical Co Ltd

Kyongbo Pharmaceutical Co., Ltd manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and internationally. The company offers general, cephalosporins, and anti-cancer APIs; prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics; and OTC drugs. It also provides medical devices, including portable X-ray machine and ultrasonic diagnostic equipment; and extraporeal shockwave therapy and temperature control PROBE.…

Full company profile